Tag Archives: AI drug discovery

June 23, 2020
In The News

The University of Kentucky announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies. The project awarded to Dr. Konstantin V. Korotkov is part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) awards program, which seeks to democratize access to AI for drug […]

Read Article
June 22, 2020
In The News

University of Connecticut professor of molecular and cell biology James Cole is working on identifying new therapeutics for COVID-19. Through a collaboration with Atomwise, Cole is one of the 15 researchers looking at different coronavirus protein targets for COVID-19 treatment.

Read Article
May 18, 2020
In The News

A UniSA molecular biologist is working with a world leader in artificial intelligence-based drug discovery to help find a molecule that could prevent the SARS-CoV-2 coronavirus strain causing COVID-19 from infecting human cells.

Read Article
January 7, 2020
Press Release

Companies to continue crop protection development programs January 07, 2020 08:30 AM Eastern Standard Time MONHEIM, Germany & SAN FRANCISCO–(BUSINESS WIRE)–Bayer and Atomwise, the leader in artificial intelligence (AI) for drug discovery, today announced the companies will continue the development of two crop protection programs. Farmers across the world are facing an increase in weed, insect and […]

Read Article
September 27, 2019
In The News

Angus Liu of FierceBiotech reports on new research on Miro1 and implications for Parkinson’s disease.

Read Article
September 26, 2019
In The News

Science Daily reports on a recent publication by researchers at Stanford, Mayo Clinic, and Atomwise.

Read Article